Detalhe da pesquisa
1.
Therapeutic Small Interfering RNA Targeting Complement C3 in a Mouse Model of C3 Glomerulopathy.
J Immunol
; 208(7): 1772-1781, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35277417
2.
Empagliflozin protects glomerular endothelial cell architecture in experimental diabetes through the VEGF-A/caveolin-1/PV-1 signaling pathway.
J Pathol
; 256(4): 468-479, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35000230
3.
Endothelial Glycocalyx of Peritubular Capillaries in Experimental Diabetic Nephropathy: A Target of ACE Inhibitor-Induced Kidney Microvascular Protection.
Int J Mol Sci
; 24(22)2023 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38003732
4.
Sirtuin 3 Deficiency Aggravates Kidney Disease in Response to High-Fat Diet through Lipotoxicity-Induced Mitochondrial Damage.
Int J Mol Sci
; 23(15)2022 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35955472
5.
Addition of cyclic angiotensin-(1-7) to angiotensin-converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathy.
Kidney Int
; 96(4): 906-917, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31307778
6.
Shiga toxin triggers endothelial and podocyte injury: the role of complement activation.
Pediatr Nephrol
; 34(3): 379-388, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29214442
7.
MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathy.
Diabetologia
; 60(6): 1114-1125, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28364255
8.
B7-1 Is Not Induced in Podocytes of Human and Experimental Diabetic Nephropathy.
J Am Soc Nephrol
; 27(4): 999-1005, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26319246
9.
Key pathways in renal disease progression of experimental diabetes.
Nephrol Dial Transplant
; 30 Suppl 4: iv54-9, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26209738
10.
Progression of renal injury toward interstitial inflammation and glomerular sclerosis is dependent on abnormal protein filtration.
Nephrol Dial Transplant
; 30(5): 706-12, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25087196
11.
Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement.
J Am Soc Nephrol
; 25(8): 1786-98, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24578132
12.
ß-arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury.
J Am Soc Nephrol
; 25(3): 523-33, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24371298
13.
The Nrf2 pathway in the progression of renal disease.
Nephrol Dial Transplant
; 29 Suppl 1: i19-i24, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23761459
14.
Lack of the lectin-like domain of thrombomodulin worsens Shiga toxin-associated hemolytic uremic syndrome in mice.
J Immunol
; 189(7): 3661-8, 2012 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22942429
15.
Efficacy of GalNAc C3 siRNAs in factor H-deficient mice with C3 glomerulopathy.
Mol Immunol
; 168: 10-16, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38368725
16.
Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.
J Immunol
; 187(1): 172-80, 2011 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21642543
17.
Liver factor B silencing to cure C3 glomerulopathy: Evidence from a mouse model of complement dysregulation.
Mol Immunol
; 161: 25-32, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37481826
18.
Thyroid hormone treatment counteracts cellular phenotypical remodeling in diabetic organs.
iScience
; 26(10): 107826, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37752946
19.
Add-On Cyclic Angiotensin-(1-7) with Cyclophosphamide Arrests Progressive Kidney Disease in Rats with ANCA Associated Glomerulonephritis.
Cells
; 11(15)2022 08 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35954280
20.
Low Nephron Number Induced by Maternal Protein Restriction Is Prevented by Nicotinamide Riboside Supplementation Depending on Sirtuin 3 Activation.
Cells
; 11(20)2022 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36291179